Table of Content

1 Report Overview
1.1 Finasteride Tablets Definition
1.2 Market by Type
1.2.1 Global Finasteride Tablets Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Market Segment by Application
1.3.1 Global Finasteride Tablets Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Benign Prostatic Hyperplasia
1.3.3 Male Pattern Baldness
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Finasteride Tablets Sales
2.1 Global Finasteride Tablets Revenue Estimates and Forecasts 2018-2034
2.2 Global Finasteride Tablets Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Finasteride Tablets Revenue by Region
2.3.1 Global Finasteride Tablets Revenue by Region (2018-2023)
2.3.2 Global Finasteride Tablets Revenue by Region (2024-2034)
2.4 Global Finasteride Tablets Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Finasteride Tablets Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Finasteride Tablets Sales Quantity by Region
2.6.1 Global Finasteride Tablets Sales Quantity by Region (2018-2023)
2.6.2 Global Finasteride Tablets Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Finasteride Tablets Sales Quantity by Manufacturers
3.1.1 Global Finasteride Tablets Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Finasteride Tablets Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Finasteride Tablets Sales in 2024
3.2 Global Finasteride Tablets Revenue by Manufacturers
3.2.1 Global Finasteride Tablets Revenue by Manufacturers (2018-2023)
3.2.2 Global Finasteride Tablets Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Finasteride Tablets Revenue in 2024
3.3 Global Finasteride Tablets Sales Price by Manufacturers
3.4 Global Key Players of Finasteride Tablets, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Finasteride Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Finasteride Tablets, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Finasteride Tablets, Product Offered and Application
3.8 Global Key Manufacturers of Finasteride Tablets, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Finasteride Tablets Sales Quantity by Type
4.1.1 Global Finasteride Tablets Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Finasteride Tablets Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Finasteride Tablets Sales Quantity Market Share by Type (2018-2034)
4.2 Global Finasteride Tablets Revenue by Type
4.2.1 Global Finasteride Tablets Historical Revenue by Type (2018-2023)
4.2.2 Global Finasteride Tablets Forecasted Revenue by Type (2024-2034)
4.2.3 Global Finasteride Tablets Revenue Market Share by Type (2018-2034)
4.3 Global Finasteride Tablets Price by Type
4.3.1 Global Finasteride Tablets Price by Type (2018-2023)
4.3.2 Global Finasteride Tablets Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Finasteride Tablets Sales Quantity by Application
5.1.1 Global Finasteride Tablets Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Finasteride Tablets Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Finasteride Tablets Sales Quantity Market Share by Application (2018-2034)
5.2 Global Finasteride Tablets Revenue by Application
5.2.1 Global Finasteride Tablets Historical Revenue by Application (2018-2023)
5.2.2 Global Finasteride Tablets Forecasted Revenue by Application (2024-2034)
5.2.3 Global Finasteride Tablets Revenue Market Share by Application (2018-2034)
5.3 Global Finasteride Tablets Price by Application
5.3.1 Global Finasteride Tablets Price by Application (2018-2023)
5.3.2 Global Finasteride Tablets Price Forecast by Application (2024-2034)
6 North America
6.1 North America Finasteride Tablets Sales by Company
6.1.1 North America Finasteride Tablets Revenue by Company (2018-2023)
6.1.2 North America Finasteride Tablets Sales Quantity by Company (2018-2023)
6.2 North America Finasteride Tablets Market Size by Type
6.2.1 North America Finasteride Tablets Sales Quantity by Type (2018-2034)
6.2.2 North America Finasteride Tablets Revenue by Type (2018-2034)
6.3 North America Finasteride Tablets Market Size by Application
6.3.1 North America Finasteride Tablets Sales Quantity by Application (2018-2034)
6.3.2 North America Finasteride Tablets Revenue by Application (2018-2034)
6.4 North America Finasteride Tablets Market Size by Country
6.4.1 North America Finasteride Tablets Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Finasteride Tablets Revenue by Country (2018-2034)
6.4.3 North America Finasteride Tablets Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Finasteride Tablets Sales by Company
7.1.1 Europe Finasteride Tablets Sales Quantity by Company (2018-2023)
7.1.2 Europe Finasteride Tablets Revenue by Company (2018-2023)
7.2 Europe Finasteride Tablets Market Size by Type
7.2.1 Europe Finasteride Tablets Sales Quantity by Type (2018-2034)
7.2.2 Europe Finasteride Tablets Revenue by Type (2018-2034)
7.3 Europe Finasteride Tablets Market Size by Application
7.3.1 Europe Finasteride Tablets Sales Quantity by Application (2018-2034)
7.3.2 Europe Finasteride Tablets Revenue by Application (2018-2034)
7.4 Europe Finasteride Tablets Market Size by Country
7.4.1 Europe Finasteride Tablets Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Finasteride Tablets Revenue by Country (2018-2034)
7.4.3 Europe Finasteride Tablets Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Finasteride Tablets Sales by Company
8.1.1 China Finasteride Tablets Sales Quantity by Company (2018-2023)
8.1.2 China Finasteride Tablets Revenue by Company (2018-2023)
8.2 China Finasteride Tablets Market Size by Type
8.2.1 China Finasteride Tablets Sales Quantity by Type (2018-2034)
8.2.2 China Finasteride Tablets Revenue by Type (2018-2034)
8.3 China Finasteride Tablets Market Size by Application
8.3.1 China Finasteride Tablets Sales Quantity by Application (2018-2034)
8.3.2 China Finasteride Tablets Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Finasteride Tablets Sales by Company
9.1.1 APAC Finasteride Tablets Sales Quantity by Company (2018-2023)
9.1.2 APAC Finasteride Tablets Revenue by Company (2018-2023)
9.2 APAC Finasteride Tablets Market Size by Type
9.2.1 APAC Finasteride Tablets Sales Quantity by Type (2018-2034)
9.2.2 APAC Finasteride Tablets Revenue by Type (2018-2034)
9.3 APAC Finasteride Tablets Market Size by Application
9.3.1 APAC Finasteride Tablets Sales Quantity by Application (2018-2034)
9.3.2 APAC Finasteride Tablets Revenue by Application (2018-2034)
9.4 APAC Finasteride Tablets Market Size by Region
9.4.1 APAC Finasteride Tablets Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Finasteride Tablets Revenue by Region (2018-2034)
9.4.3 APAC Finasteride Tablets Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Finasteride Tablets Sales by Company
10.1.1 Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Finasteride Tablets Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Finasteride Tablets Market Size by Type
10.2.1 Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Finasteride Tablets Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Finasteride Tablets Market Size by Application
10.3.1 Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Finasteride Tablets Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Finasteride Tablets Market Size by Country
10.4.1 Middle East, Africa and Latin America Finasteride Tablets Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Finasteride Tablets Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Merck Finasteride Tablets Products and Services
11.1.5 Merck Finasteride Tablets SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Actavis
11.2.1 Actavis Company Information
11.2.2 Actavis Overview
11.2.3 Actavis Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Actavis Finasteride Tablets Products and Services
11.2.5 Actavis Finasteride Tablets SWOT Analysis
11.2.6 Actavis Recent Developments
11.3 Sandoz
11.3.1 Sandoz Company Information
11.3.2 Sandoz Overview
11.3.3 Sandoz Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Sandoz Finasteride Tablets Products and Services
11.3.5 Sandoz Finasteride Tablets SWOT Analysis
11.3.6 Sandoz Recent Developments
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Information
11.4.2 Teva Pharmaceuticals Overview
11.4.3 Teva Pharmaceuticals Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Teva Pharmaceuticals Finasteride Tablets Products and Services
11.4.5 Teva Pharmaceuticals Finasteride Tablets SWOT Analysis
11.4.6 Teva Pharmaceuticals Recent Developments
11.5 Cipla
11.5.1 Cipla Company Information
11.5.2 Cipla Overview
11.5.3 Cipla Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Cipla Finasteride Tablets Products and Services
11.5.5 Cipla Finasteride Tablets SWOT Analysis
11.5.6 Cipla Recent Developments
11.6 RelonChem
11.6.1 RelonChem Company Information
11.6.2 RelonChem Overview
11.6.3 RelonChem Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 RelonChem Finasteride Tablets Products and Services
11.6.5 RelonChem Finasteride Tablets SWOT Analysis
11.6.6 RelonChem Recent Developments
11.7 Dr. Reddy
11.7.1 Dr. Reddy Company Information
11.7.2 Dr. Reddy Overview
11.7.3 Dr. Reddy Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Dr. Reddy Finasteride Tablets Products and Services
11.7.5 Dr. Reddy Finasteride Tablets SWOT Analysis
11.7.6 Dr. Reddy Recent Developments
11.8 Accord Pharmaceuticals
11.8.1 Accord Pharmaceuticals Company Information
11.8.2 Accord Pharmaceuticals Overview
11.8.3 Accord Pharmaceuticals Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Accord Pharmaceuticals Finasteride Tablets Products and Services
11.8.5 Accord Pharmaceuticals Finasteride Tablets SWOT Analysis
11.8.6 Accord Pharmaceuticals Recent Developments
11.9 Henan Topfond
11.9.1 Henan Topfond Company Information
11.9.2 Henan Topfond Overview
11.9.3 Henan Topfond Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Henan Topfond Finasteride Tablets Products and Services
11.9.5 Henan Topfond Finasteride Tablets SWOT Analysis
11.9.6 Henan Topfond Recent Developments
11.10 Zhejiang CONBA Pharmaceutical
11.10.1 Zhejiang CONBA Pharmaceutical Company Information
11.10.2 Zhejiang CONBA Pharmaceutical Overview
11.10.3 Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Zhejiang CONBA Pharmaceutical Finasteride Tablets Products and Services
11.10.5 Zhejiang CONBA Pharmaceutical Finasteride Tablets SWOT Analysis
11.10.6 Zhejiang CONBA Pharmaceutical Recent Developments
11.11 Shandong Renhetang Pharmaceutical
11.11.1 Shandong Renhetang Pharmaceutical Company Information
11.11.2 Shandong Renhetang Pharmaceutical Overview
11.11.3 Shandong Renhetang Pharmaceutical Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Shandong Renhetang Pharmaceutical Finasteride Tablets Products and Services
11.11.5 Shandong Renhetang Pharmaceutical Recent Developments
11.12 Guangdong Eashu Pharmacetical
11.12.1 Guangdong Eashu Pharmacetical Company Information
11.12.2 Guangdong Eashu Pharmacetical Overview
11.12.3 Guangdong Eashu Pharmacetical Finasteride Tablets Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Guangdong Eashu Pharmacetical Finasteride Tablets Products and Services
11.12.5 Guangdong Eashu Pharmacetical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Finasteride Tablets Value Chain Analysis
12.2 Finasteride Tablets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Finasteride Tablets Production Mode & Process
12.4 Finasteride Tablets Sales and Marketing
12.4.1 Finasteride Tablets Sales Channels
12.4.2 Finasteride Tablets Distributors
12.5 Finasteride Tablets Customers
13 Market Dynamics
13.1 Finasteride Tablets Industry Trends
13.2 Finasteride Tablets Market Drivers
13.3 Finasteride Tablets Market Challenges
13.4 Finasteride Tablets Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Finasteride Tablets Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 1mg Tablet
Table 3. Major Manufacturers of 5mg Tablet
Table 4. Global Finasteride Tablets Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Finasteride Tablets Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Finasteride Tablets Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Finasteride Tablets Revenue Market Share by Region (2018-2023)
Table 8. Global Finasteride Tablets Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Finasteride Tablets Revenue Market Share by Region (2024-2034)
Table 10. Global Finasteride Tablets Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Finasteride Tablets Sales by Region (2018-2023) & (K Units)
Table 12. Global Finasteride Tablets Sales Market Share by Region (2018-2023)
Table 13. Global Finasteride Tablets Sales by Region (2024-2034) & (K Units)
Table 14. Global Finasteride Tablets Sales Market Share by Region (2024-2034)
Table 15. Global Finasteride Tablets Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Finasteride Tablets Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Finasteride Tablets Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Finasteride Tablets Revenue Share by Manufacturers (2018-2023)
Table 19. Global Finasteride Tablets Price by Manufacturers 2018-2023 (USD/Unit)
Table 20. Global Key Players of Finasteride Tablets, Industry Ranking, 2021 VS 2024
Table 21. Global Finasteride Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Finasteride Tablets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Finasteride Tablets as of 2024)
Table 23. Global Key Manufacturers of Finasteride Tablets, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Finasteride Tablets, Product Offered and Application
Table 25. Global Key Manufacturers of Finasteride Tablets, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Finasteride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Finasteride Tablets Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Finasteride Tablets Sales Quantity Share by Type (2018-2023)
Table 30. Global Finasteride Tablets Sales Quantity Share by Type (2024-2034)
Table 31. Global Finasteride Tablets Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Finasteride Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Finasteride Tablets Revenue Share by Type (2018-2023)
Table 34. Global Finasteride Tablets Revenue Share by Type (2024-2034)
Table 35. Finasteride Tablets Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Finasteride Tablets Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Finasteride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Finasteride Tablets Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Finasteride Tablets Sales Quantity Share by Application (2018-2023)
Table 40. Global Finasteride Tablets Sales Quantity Share by Application (2024-2034)
Table 41. Global Finasteride Tablets Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Finasteride Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Finasteride Tablets Revenue Share by Application (2018-2023)
Table 44. Global Finasteride Tablets Revenue Share by Application (2024-2034)
Table 45. Finasteride Tablets Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Finasteride Tablets Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Finasteride Tablets Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Finasteride Tablets Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Finasteride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Finasteride Tablets Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Finasteride Tablets Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Finasteride Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Finasteride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Finasteride Tablets Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Finasteride Tablets Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Finasteride Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Finasteride Tablets Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Finasteride Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Finasteride Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Finasteride Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Finasteride Tablets Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Finasteride Tablets Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Finasteride Tablets Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Finasteride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Finasteride Tablets Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Finasteride Tablets Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Finasteride Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Finasteride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Finasteride Tablets Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Finasteride Tablets Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Finasteride Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Finasteride Tablets Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Finasteride Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Finasteride Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Finasteride Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Finasteride Tablets Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Finasteride Tablets Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Finasteride Tablets Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Finasteride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Finasteride Tablets Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Finasteride Tablets Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Finasteride Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Finasteride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Finasteride Tablets Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Finasteride Tablets Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Finasteride Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Finasteride Tablets Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Finasteride Tablets Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Finasteride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Finasteride Tablets Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Finasteride Tablets Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Finasteride Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Finasteride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Finasteride Tablets Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Finasteride Tablets Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Finasteride Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Finasteride Tablets Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Finasteride Tablets Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Finasteride Tablets Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Finasteride Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Finasteride Tablets Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Finasteride Tablets Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Finasteride Tablets Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Finasteride Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Finasteride Tablets Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Finasteride Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Finasteride Tablets Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Finasteride Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Finasteride Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Merck Company Information
Table 118. Merck Description and Overview
Table 119. Merck Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 120. Merck Finasteride Tablets Product and Services
Table 121. Merck Finasteride Tablets SWOT Analysis
Table 122. Merck Recent Developments
Table 123. Actavis Company Information
Table 124. Actavis Description and Overview
Table 125. Actavis Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 126. Actavis Finasteride Tablets Product and Services
Table 127. Actavis Finasteride Tablets SWOT Analysis
Table 128. Actavis Recent Developments
Table 129. Sandoz Company Information
Table 130. Sandoz Description and Overview
Table 131. Sandoz Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 132. Sandoz Finasteride Tablets Product and Services
Table 133. Sandoz Finasteride Tablets SWOT Analysis
Table 134. Sandoz Recent Developments
Table 135. Teva Pharmaceuticals Company Information
Table 136. Teva Pharmaceuticals Description and Overview
Table 137. Teva Pharmaceuticals Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 138. Teva Pharmaceuticals Finasteride Tablets Product and Services
Table 139. Teva Pharmaceuticals Finasteride Tablets SWOT Analysis
Table 140. Teva Pharmaceuticals Recent Developments
Table 141. Cipla Company Information
Table 142. Cipla Description and Overview
Table 143. Cipla Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 144. Cipla Finasteride Tablets Product and Services
Table 145. Cipla Finasteride Tablets SWOT Analysis
Table 146. Cipla Recent Developments
Table 147. RelonChem Company Information
Table 148. RelonChem Description and Overview
Table 149. RelonChem Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 150. RelonChem Finasteride Tablets Product and Services
Table 151. RelonChem Finasteride Tablets SWOT Analysis
Table 152. RelonChem Recent Developments
Table 153. Dr. Reddy Company Information
Table 154. Dr. Reddy Description and Overview
Table 155. Dr. Reddy Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 156. Dr. Reddy Finasteride Tablets Product and Services
Table 157. Dr. Reddy Finasteride Tablets SWOT Analysis
Table 158. Dr. Reddy Recent Developments
Table 159. Accord Pharmaceuticals Company Information
Table 160. Accord Pharmaceuticals Description and Overview
Table 161. Accord Pharmaceuticals Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 162. Accord Pharmaceuticals Finasteride Tablets Product and Services
Table 163. Accord Pharmaceuticals Finasteride Tablets SWOT Analysis
Table 164. Accord Pharmaceuticals Recent Developments
Table 165. Henan Topfond Company Information
Table 166. Henan Topfond Description and Overview
Table 167. Henan Topfond Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 168. Henan Topfond Finasteride Tablets Product and Services
Table 169. Henan Topfond Finasteride Tablets SWOT Analysis
Table 170. Henan Topfond Recent Developments
Table 171. Zhejiang CONBA Pharmaceutical Company Information
Table 172. Zhejiang CONBA Pharmaceutical Description and Overview
Table 173. Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 174. Zhejiang CONBA Pharmaceutical Finasteride Tablets Product and Services
Table 175. Zhejiang CONBA Pharmaceutical Finasteride Tablets SWOT Analysis
Table 176. Zhejiang CONBA Pharmaceutical Recent Developments
Table 177. Shandong Renhetang Pharmaceutical Company Information
Table 178. Shandong Renhetang Pharmaceutical Description and Overview
Table 179. Shandong Renhetang Pharmaceutical Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 180. Shandong Renhetang Pharmaceutical Finasteride Tablets Product and Services
Table 181. Shandong Renhetang Pharmaceutical Recent Developments
Table 182. Guangdong Eashu Pharmacetical Company Information
Table 183. Guangdong Eashu Pharmacetical Description and Overview
Table 184. Guangdong Eashu Pharmacetical Finasteride Tablets Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 185. Guangdong Eashu Pharmacetical Finasteride Tablets Product and Services
Table 186. Guangdong Eashu Pharmacetical Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Finasteride Tablets Distributors List
Table 190. Finasteride Tablets Customers List
Table 191. Finasteride Tablets Market Trends
Table 192. Finasteride Tablets Market Drivers
Table 193. Finasteride Tablets Market Challenges
Table 194. Finasteride Tablets Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Finasteride Tablets Product Picture
Figure 2. Global Finasteride Tablets Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Finasteride Tablets Market Share by Type in 2024 & 2034
Figure 4. 1mg Tablet Product Picture
Figure 5. 5mg Tablet Product Picture
Figure 6. Global Finasteride Tablets Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Finasteride Tablets Market Share by Application in 2024 & 2034
Figure 8. Benign Prostatic Hyperplasia
Figure 9. Male Pattern Baldness
Figure 10. Others
Figure 11. Finasteride Tablets Report Years Considered
Figure 12. Global Finasteride Tablets Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Finasteride Tablets Revenue 2018-2034 (US$ Million)
Figure 14. Global Finasteride Tablets Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 15. Global Finasteride Tablets Sales Quantity 2018-2034 (K Units)
Figure 16. Global Finasteride Tablets Sales Quantity Market Share by Region (2018-2023)
Figure 17. Global Finasteride Tablets Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Finasteride Tablets Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Finasteride Tablets Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Finasteride Tablets Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Finasteride Tablets Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Finasteride Tablets Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Finasteride Tablets Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Finasteride Tablets Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Finasteride Tablets Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Finasteride Tablets Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Finasteride Tablets Sales Quantity in 2024
Figure 29. The Top 10 and Top 5 Players Market Share by Finasteride Tablets Revenue in 2024
Figure 30. Finasteride Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 31. Global Finasteride Tablets Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Finasteride Tablets Revenue Market Share by Type (2018-2034)
Figure 33. Global Finasteride Tablets Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Finasteride Tablets Revenue Market Share by Application (2018-2034)
Figure 35. North America Finasteride Tablets Revenue Market Share by Company in 2024
Figure 36. North America Finasteride Tablets Sales Quantity Market Share by Company in 2024
Figure 37. North America Finasteride Tablets Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Finasteride Tablets Revenue Market Share by Type (2018-2034)
Figure 39. North America Finasteride Tablets Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Finasteride Tablets Revenue Market Share by Application (2018-2034)
Figure 41. North America Finasteride Tablets Revenue Share by Country (2018-2034)
Figure 42. North America Finasteride Tablets Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Finasteride Tablets Sales Quantity Market Share by Company in 2024
Figure 46. Europe Finasteride Tablets Revenue Market Share by Company in 2024
Figure 47. Europe Finasteride Tablets Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Finasteride Tablets Revenue Market Share by Type (2018-2034)
Figure 49. Europe Finasteride Tablets Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Finasteride Tablets Revenue Market Share by Application (2018-2034)
Figure 51. Europe Finasteride Tablets Revenue Share by Country (2018-2034)
Figure 52. Europe Finasteride Tablets Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 54. France Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 58. China Finasteride Tablets Sales Quantity Market Share by Company in 2024
Figure 59. China Finasteride Tablets Revenue Market Share by Company in 2024
Figure 60. China Finasteride Tablets Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Finasteride Tablets Revenue Market Share by Type (2018-2034)
Figure 62. China Finasteride Tablets Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Finasteride Tablets Revenue Market Share by Application (2018-2034)
Figure 64. APAC Finasteride Tablets Sales Quantity Market Share by Company in 2024
Figure 65. APAC Finasteride Tablets Revenue Market Share by Company in 2024
Figure 66. APAC Finasteride Tablets Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Finasteride Tablets Revenue Market Share by Type (2018-2034)
Figure 68. APAC Finasteride Tablets Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Finasteride Tablets Revenue Market Share by Application (2018-2034)
Figure 70. APAC Finasteride Tablets Revenue Share by Region (2018-2034)
Figure 71. APAC Finasteride Tablets Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 76. India Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Finasteride Tablets Revenue Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Finasteride Tablets Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Finasteride Tablets Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Finasteride Tablets Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Finasteride Tablets Revenue Share by Country (2018-2034)
Figure 85. Brazil Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Finasteride Tablets Revenue (2018-2034) & (US$ Million)
Figure 90. Finasteride Tablets Value Chain
Figure 91. Finasteride Tablets Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed